Related Experiment Videos
Detection of activated platelet-derived growth factor receptors in human meningioma
S M Shamah1, J A Alberta, W V Giannobile
1Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract:
The beta receptor subunit of platelet-derived growth factor (PDGF) and its corresponding ligand (PDGF-BB) are coordinately expressed in fresh surgical isolates of human meningioma. These observations imply that PDGF autocrine loops are engaged in human meningioma and suggest that activated PDGF-beta receptors might contribute to the pathology of this common brain neoplasm. The study of PDGF autocrine loops and human meningioma has been slowed by the scarcity of meningioma cell culture model systems. Furthermore, in meningioma tumor tissue, the activation state of PDGF receptors is difficult to assess with conventional reagents, because the tumor is intermixed with normal stroma. In fact, there is no evidence that PDGF receptors within the tumor are activated by ligand. We used a synthetic tyrosine phosphopeptide to raise an antibody that reports the phosphorylation state of tyrosine 751 in the human PDGF-beta receptor. Phosphorylated tyrosine 751 is a recognition site for phosphatidylinositol 3'-kinase, a cytoplasmic effector of PDGF-induced mitogenesis, chemotaxis, and membrane ruffling. Immunoblotting and immunostaining analyses with this antibody show that the PDGF-beta receptor is constitutively phosphorylated at tyrosine 751 within multiple fresh surgical isolates of human meningioma. These findings are consistent with a role for activated PDGF receptors in the proliferation of human meningiomas.
Insights
Platelet-derived growth factor (PDGF) signaling is active in human meningiomas. Activated PDGF-beta receptors are constitutively phosphorylated, suggesting a role in brain tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Neuroscience
Background:
- Platelet-derived growth factor (PDGF) and its beta receptor subunit are expressed in human meningiomas.
- Autocrine PDGF signaling is implicated in meningioma development.
- Assessing PDGF receptor activation in tumors is challenging due to tissue complexity.
Purpose of the Study:
- To investigate the activation state of PDGF-beta receptors in human meningiomas.
- To develop a tool to detect activated PDGF-beta receptors in tumor tissue.
Main Methods:
- Raised an antibody targeting phosphorylated tyrosine 751 on the PDGF-beta receptor.
- Utilized immunoblotting and immunostaining techniques.
- Analyzed fresh surgical isolates of human meningioma.
Main Results:
- The PDGF-beta receptor is constitutively phosphorylated at tyrosine 751 in human meningiomas.
- Phosphotyrosine 751 is a key site for phosphatidylinositol 3'-kinase interaction.
- This phosphorylation indicates active PDGF signaling pathways.
Conclusions:
- Activated PDGF-beta receptors are present in human meningiomas.
- Constitutive PDGF receptor phosphorylation suggests a role in meningioma proliferation.
- Findings support targeting PDGF signaling in meningioma treatment.